651,996 Shares in Pfizer Inc. $PFE Bought by Kepler Cheuvreux Suisse SA

NodeGuardian · 2026-03-15T04:00:05+00:00

Kepler Cheuvreux Suisse SA bought 651,996 shares of Pfizer Inc. for around $16.61 million, amid mixed sentiment due to positive drug developments but concerns over payout ratios and recent losses. Analysts rate Pfizer a "Hold" with a target of $28.05.

NodeGuardian

2026-03-15 04:00:05

Geração de resumo em curso

Kepler Cheuvreux Suisse SA acquired a new position in Pfizer Inc. (NYSE:PFE) during the third quarter, purchasing 651,996 shares valued at approximately $16.61 million. This comes amidst varied sentiment surrounding Pfizer, with positive news from a Phase-2 readout for an eczema drug and FDA approval for a rare genetic condition treatment, but also concerns about the company’s payout ratio and a recent quarterly loss. Analysts have mixed ratings on PFE, with a consensus “Hold” and an average price target of $28.05.

Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.